Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
about
Oxidative Stress Signaling in Alzheimers DiseaseApolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseAlzheimer mechanisms and therapeutic strategiesApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyRosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsAPOE genotype and stress response - a mini reviewApolipoprotein E: from cardiovascular disease to neurodegenerative disordersPolyallelic structural variants can provide accurate, highly informative genetic markers focused on diagnosis and therapeutic targets: Accuracy vs. PrecisionReevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle ModelProteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's diseaseOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseTriad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal SexProteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challengeThe ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated miceBeneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer's disease.Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathologyPathogenesis of Alzheimer's diseaseGABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctorsPrediction of the functional class of metal-binding proteins from sequence derived physicochemical properties by support vector machine approachMolecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.Genetic variation at a single locus and age of onset for Alzheimer's disease.The Alzheimer's disease mitochondrial cascade hypothesisAssociation of hypometabolism and amyloid levels in aging, normal subjectsAn apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseA mitochondrial etiology of Alzheimer and Parkinson diseaseSystemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in miceApolipoprotein E: from lipid transport to neurobiologyThe role of apolipoprotein E in Alzheimer's disease.Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development.C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice.Mass spectrometry quantification revealed accumulation of C-terminal fragment of apolipoprotein E in the Alzheimer's frontal cortex.
P2860
Q22241327-B9B48401-838C-4F54-8B04-AA4C831D669CQ22248091-995F98E0-0EB2-4D95-A19A-D62790A186C7Q22252311-CF144103-2916-40E2-8478-FF666520B873Q24604376-6F63CB09-85FE-49B3-A318-A87075AB8659Q24652687-88DDCCF8-BDCA-46E9-92C8-07D081C2E49FQ26741633-DFAAEDAE-382C-4D92-A03E-6645B79B0A7DQ26747482-CEF061D4-ADF1-4E33-ABB5-B73BB10E3F41Q26777805-484FB0F7-F889-4F98-A205-5A7A3CC45F41Q26864926-E60CE18C-67FB-4E25-82AC-6A42851C9E59Q27011311-D5A26804-7245-49E5-832D-34CCEF9BEE22Q27023315-8059CAEE-AD58-4B45-85AE-D321BB142236Q28077056-DE1E9E87-2E79-4D19-A2C3-C25B93730024Q28730678-00EAD6B1-B9D2-4A47-8895-5D2C977AF24CQ28742884-9F93E946-7466-4DEB-AF01-36CD593DE472Q30358683-86CA9470-85A8-4FDA-8D4F-7AF2003C72DFQ30421643-EA9703F8-B9FC-4AE5-9863-D563B9DE1011Q30439489-461F88DF-BC5E-4B6A-836D-A165ACDBE66FQ30497475-B3AC6BD8-2C9E-4C48-BB16-74BD15CA932BQ30500121-CDF87EDF-6490-40A5-A6EB-B78C1F756797Q33270374-4445D450-57D6-4F00-BF2C-505A72137394Q33556316-E1AB5D90-2695-40D2-AF0F-AEBC60C023D2Q33607473-D6ABB8E2-3B56-4F2B-85D0-79B75A433F91Q33870512-0F263EC1-851E-45CF-BBC1-B7C963C33858Q33905871-CDE727BB-EEA1-495B-BF1A-75266C98601CQ33927230-18AF672B-1C01-4AF5-9D34-FFF3F8D026A1Q34020742-CE6E424D-2DCA-44B1-B49B-BD0CDF80A7FAQ34034409-FC8DEB07-D73A-4716-89E8-383E328A9224Q34096644-2732989B-FE82-487A-BAF3-A8AACEC30223Q34159318-726BBDA7-DC3C-428F-BAF2-8BA50882A7E0Q34211127-07122CC7-CCB0-47A1-AF24-8342D32E1ED2Q34246990-709469E2-B27A-4B44-AA5A-1F0A9E48D78CQ34303501-4986A0F4-47D2-4265-8160-A16BA7577A4CQ34345696-6ACF524E-03F3-4C4D-870B-046C1D90F823Q34497951-8A205EF5-74ED-4F67-A3DF-21EF7871E504Q34603092-E58D135E-C163-4B86-B87A-628B40C826FDQ34621541-8EFEB243-3E95-4D51-AD5B-77BE9E8DD900Q34628212-E013719C-7FDA-42CD-9B0B-E07D8162BF5AQ34635216-ED0DF3C6-B8A4-4579-AF9A-7877B80A87DDQ34651878-D18601A2-C396-46F8-ABE8-37054DDEF447Q34674992-639F36C3-78F8-431F-AD2C-E447FB7A2EC9
P2860
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@ast
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@en
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@nl
type
label
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@ast
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@en
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@nl
prefLabel
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@ast
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@en
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@nl
P2093
P2860
P356
P1476
Lipid- and receptor-binding re ...... dysfunction and neurotoxicity
@en
P2093
Maureen E Balestra
R Dennis Miranda
Robert W Mahley
Shengjun Chang
Tian ran Ma
Yadong Huang
P2860
P304
18694-18699
P356
10.1073/PNAS.0508254102
P407
P577
2005-12-12T00:00:00Z